TY  - GEN
AU  - Rowe,Jacob M
TI  - Will new agents impact survival in AML?
SN  - 1532-1924
PY  - 2020///0513
KW  - Aniline Compounds
KW  - therapeutic use
KW  - Disease-Free Survival
KW  - Drug Approval
KW  - Gemtuzumab
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Pyrazines
KW  - Staurosporine
KW  - analogs & derivatives
KW  - Survival Rate
KW  - United States
KW  - epidemiology
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.beha.2019.101094
ER  -